Predisposing factors in the Spondyloarthropathies: New insights into the role of HLA-B27
- 1 October 2001
- journal article
- review article
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 3 (5) , 404-411
- https://doi.org/10.1007/s11926-996-0011-9
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- INTERLEUKIN 1 GENE CLUSTER POLYMORPHISMS IN MULTIPLEX FAMILIES WITH SPONDYLARTHROPATHIESCytokine, 2001
- Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitisAnnals of the Rheumatic Diseases, 2000
- HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibilityHuman Immunology, 2000
- Molecular Mimicry and AutoimmunityNew England Journal of Medicine, 1999
- Polymorphism within the tumor necrosis factor α (TNF) promoter region in patients with ankylosing spondylitisHuman Immunology, 1999
- Reactivity and Specificity of CD8+ T Cells in Mice with Defects in the MHC Class I Antigen‐Presenting PathwayImmunological Reviews, 1996
- The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.The Journal of Experimental Medicine, 1996
- Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies.The Journal of Experimental Medicine, 1995
- HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic miceHuman Immunology, 1995
- Differences in peptide presentation between B27 subtypes: The importance of the P1 side chain in maintaining high affinity peptide binding to B★2703Immunity, 1994